SKSalar Husein Karim

Salar Husein Karim

*This is an algorithmically generated author record based on publicly available information.

Salar Husein Karim has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Heat Shock Protein for Use in Cancer Vaccine Therapy: Immune Response and Immunotherapy

    by Dzhumaeva Lazokatkhon, Hazim Abdul Rahman Alhiti, Othman Farooq Bakr, Mudhafar A. Shafiq, Thamer Al-Hilfi, Salar Husein Karim

    Considering what was said about Heat Shock Proteins (HSPs) role in the presentation of tumor antigens, today, before using tumor cell extracts as antigens in vaccine preparation, researchers try to increase the efficiency of antigen presentation by APCs via inducing these proteins; however, since different cell lines express different amounts of HSPs under the influence of different temperatures and different incubation times, discussing the optimal temperature and post-temperature incubation for cancer cell lines that may cause the next stages of the production of cancer cell vaccines, will be very useful. Through systematic search in PubMed/Medline using ("Tumor"[Title/Abstract] OR "Cancer"[Title/Abstract] OR "Neoplasm"[Title/Abstract]) AND ("vaccine"[Title/Abstract] OR "vaccination"[Title/Abstract]) AND ("heat shock protein"[Title/Abstract] OR "HSP"[Title/Abstract]) from 1980 to 2025. Overall, 18 articles were selected from a total of 414. The results of clinical trials confirm the use of HSPs in cancer vaccine therapy. A total of 18 studies, including 1,116 cases with different forms of cancer, were reviewed. These studies spanned different trial phases (I–III) and utilized a range of HSP-based vaccines to evaluate their safety, immunogenicity, and efficacy. HSPPC-96 was the most commonly investigated vaccine. These results indicate that the specific tumor-specific effects of the HSPs' immune response, including cluster of differentiation 4 (CD4+), interferon gamma (IFN-γ), and CD8+, lead to a much stronger vaccination. These outcomes underscore the complexity of the tumor microenvironment and the necessity for tailored approaches to maximize therapeutic success. Advances in vaccine formulation, production, and combination therapies offer promising pathways to address these challenges.

  • Open Access

    Cancer immunotherapy and cardiovascular side-effects: from treatment modalities to the use of the preventive effect of antihypertensive drugs

    by Fakher Rahim, Shamim Gozin, Salar Husein Karim, Ainur Bakdauletkyzy Qumar, Kobra Doostali, Issenova Balday

    Cancer treatment regimens are significantly more intricate than commonly perceived. Nonetheless, both immunotherapy and chemotherapy may produce adverse consequences. Immunotherapy represents a significant advancement in the battle against cancer; nonetheless, it is not devoid of challenges. This research elucidates the mechanisms underlying immunotherapy-induced cardiovascular damage, highlighting the significant role of immune regulators, such as soluble urokinase plasminogen activator receptor (suPAR), in inducing vascular leakage. We also examine the role of matrix metalloproteinase (MMP14/15) in this process, and antigens associated with cardiovascular illness and malignancies, including native proteins, mutated tumor antigens, and viral components. Besides, we studied predictive biomarkers, such as circulating T-cell populations associated with the probability of myocarditis. We discuss treatment approaches and strategies to mitigate these issues, particularly through the use of antihypertensive medications to reduce their impact. Losartan alters the tumor microenvironment (TME) to improve immunotherapy. It restores immune effector cells in triple-negative breast cancer (TNBC), overcomes resistance in unresponsive tumors, and modifies TMEs’ immune system suppression in ovarian cancer and melanoma. It is important to note that its effects differ by cancer kind. It may promote fibrosarcoma tumor growth and improve cholangiocarcinoma treatment. This shows that losartan’s dangers in cancer treatment should be carefully considered and that more research is needed. This suggests that there must be careful consideration of the potential risks associated with losartan use in cancer treatment and underscores the requirement for additional research on this topic. This study may enhance our comprehension and management of cardiovascular adverse effects in cancer immunotherapy by integrating novel insights on immunological predictors and vascular dysfunction. Experts assert that oncology programs must provide and promote continuous monitoring of cardiac health for breast cancer patients. To mitigate the risk of cardiovascular disease in this demographic, comprehensive patient care must be administered.

  • Open Access

    Association of Lipid Profile with Body Mass Index in Public Employees in Halabja City, Kurdistan Region of Iraq

    by Tareq H. Abdullah, Hardi R. Baqi, Salar H. Karim, Dashti A. Ghafor

    Obesity and overweight are extensive phenomena that reached epidemics extent worldwide, including the Kurdistan region of Iraq. The aim of this study is to evaluate the values of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), body mass index (BMI), and the state of physical activity in Halabja’s public employees. Overall 355 adults aged from 19 to 63 including 246 males and 109 females contributed to the study. The lipid profiles were tested in all subjects after over-night fasting. In addition, anthropometry measurements were taken; the mean height for males is 1.7129 m and 1.5732 m for females. The mean weights of males and females are 80.4813 and 69.9459 kg, respectively. The mean BMI value for males and females is 27.4258 and 28.3274, respectively. Some of the cases were diagnosed with diabetes, renal diseases, hypertension, and other relevant diseases. 246 of participants adopted sedentary lifestyles while 109 of them lived an active lifestyle. 65, 162, 98, and 206 of participants had TC, TG, LDL-C, and HDL-C off-limits, respectively. Pearson’s correlation between BMI with TC, TG, and LDL-C showed a significant relationship at 0.01 level as 0.156**, 0.140**, and 0.144**, respectively. HDL-C was negatively correlated to BMI at −0.062 level. The analysis of variance showed statistically significant p-values between TC, TG, and HDL-C according to BMI at 0.027, 0.000, and 0.000, respectively. The sedentary group of participants showed a higher Mean range of TC, TG, LDL-C, and HDL-C than an active group of participants.